SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-13-000040
Filing Date
2013-05-08
Accepted
2013-05-08 16:09:09
Documents
13
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-331201310q.htm 10-Q 917670
2 EXHIBIT spectrumlicenseagreement-e.htm EX-10.2 451792
3 EXHIBIT spectrumsupplyagreement-ex.htm EX-10.3 112839
4 EXHIBIT lgnd-ex311_3312013.htm EX-31.1 13620
5 EXHIBIT lgnd-ex312_3312013.htm EX-31.2 13596
6 EXHIBIT lgnd-ex321_3312013.htm EX-32.1 8534
7 EXHIBIT lgnd-ex322_3312013.htm EX-32.2 8332
  Complete submission text file 0000886163-13-000040.txt   8855472

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT lgnd-20130331.xml EX-101.INS 1423209
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20130331.xsd EX-101.SCH 54904
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20130331_cal.xml EX-101.CAL 77984
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20130331_def.xml EX-101.DEF 186666
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20130331_lab.xml EX-101.LAB 754916
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20130331_pre.xml EX-101.PRE 377831
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 13824586
SIC: 2834 Pharmaceutical Preparations